menu
    • menu

    Company profile for Kinnate Biopharma

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Kinnate Biopharma, Inc. is a precision oncology company advancing a pipeline of therapeutics to treat patients with genomically defined vulnerabilities. Kinnate’s focus is on the design and development of selective small molecules with the mission to provide the right drug to the right patient. Headquartered in San Diego, CA, the Kinnate team comprises oncology experts, each with decades of experience developing small molecu...
    Kinnate Biopharma, Inc. is a precision oncology company advancing a pipeline of therapeutics to treat patients with genomically defined vulnerabilities. Kinnate’s focus is on the design and development of selective small molecules with the mission to provide the right drug to the right patient. Headquartered in San Diego, CA, the Kinnate team comprises oncology experts, each with decades of experience developing small molecule therapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Kinnate BiopharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    11975 El Camino Real, Suite 101 San Diego, CA 92130
    Telephone
    Telephone
    415.413.7627
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.kinnate.com/
    Linkedin
    Linkedin
    https://ir.linkedin.com/company/kinnate-biopharma-inc
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    XOMA Royalty Reports Q2 2024 Results And Recent Activities
    XOMA Royalty Reports Q2 2024 Results And Recent Activities

    13 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/13/2929086/7281/en/XOMA-Royalty-Reports-Second-Quarter-2024-Financial-Results-and-Highlights-Recent-Activities.html

    GLOBENEWSWIRE
    13 Aug 2024
    Share Share
    XOMA Corporation Announces Closing of Tender Offer
    XOMA Corporation Announces Closing of Tender Offer

    03 Apr 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/04/03/2857002/7281/en/XOMA-Corporation-Announces-Closing-of-Tender-Offer.html

    GLOBENEWSWIRE
    03 Apr 2024
    Share Share
    XOMA Announces Expiration Date for Tender Offer for Kinnate Biopharma Inc.
    XOMA Announces Expiration Date for Tender Offer for Kinnate Biopharma Inc.

    19 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/03/19/2848966/7281/en/XOMA-Announces-Calculation-of-Additional-Price-Per-Share-and-Extension-of-Expiration-Date-for-Tender-Offer-for-Kinnate-Biopharma-Inc.html

    GLOBENEWSWIRE
    19 Mar 2024
    Share Share
    Kinnate Sells Pan-RAF Inhibitor Exarafenib To Pierre Fabre
    Kinnate Sells Pan-RAF Inhibitor Exarafenib To Pierre Fabre

    05 Mar 2024

    // PRESS RELEASE

    https://www.pierre-fabre.com/en/press_release/kinnate-biopharma-inc-sells-its-investigational-pan-raf-inhibitor-exarafenib-to

    PRESS RELEASE
    05 Mar 2024
    Share Share
    Kinnate Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre
    Kinnate Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre

    01 Mar 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/03/01/2838802/0/en/Kinnate-Biopharma-Inc-Sells-Its-Investigational-Pan-RAF-Inhibitor-Exarafenib-to-Pierre-Fabre-Laboratories.html

    GLOBENEWSWIRE
    01 Mar 2024
    Share Share
    Kinnate Sells Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre
    Kinnate Sells Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre

    01 Mar 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/kinnate-biopharma-inc-sells-its-investigational-pan-raf-inhibitor-exarafenib-to-pierre-fabre-laboratories-302076211.html

    PR NEWSWIRE
    01 Mar 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search